192 related articles for article (PubMed ID: 8762312)
21. [Expression of proliferation markers PCNA and MIB 1 in verrucous squamous epithelial carcinoma of the oral cavity].
Theegarten D; Barfuss A; Gellrich NC; Philippou S
Mund Kiefer Gesichtschir; 1997 May; 1(3):133-6. PubMed ID: 9410620
[TBL] [Abstract][Full Text] [Related]
22. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
23. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
Krüger S; Müller H
Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
[TBL] [Abstract][Full Text] [Related]
24. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between tumor cell proliferating activity and biological behavior, prognosis in laryngeal carcinoma].
Zhou G; Liang C; Lin D; Zhang X; Wen D; Liu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):178-81. PubMed ID: 10684010
[TBL] [Abstract][Full Text] [Related]
26. [The Ljubljana classification of epithelial hyperplastic laryngeal lesions: a morphometric evaluation of nuclear pleomorphism].
Serio G; Gale N; Pennella A; Dalena AM; Giardina C; Valente T; Lettini T; Ricco R; Resta L
Pathologica; 2002 Dec; 94(6):290-8. PubMed ID: 12540992
[TBL] [Abstract][Full Text] [Related]
27. Expression of proliferation-associated proteins (proliferating cell nuclear antigen and Ki-67 antigen) in Bowen's disease.
Baum HP; Meurer I; Unteregger G
Br J Dermatol; 1994 Aug; 131(2):231-6. PubMed ID: 7917988
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of vocal cord polyps applying markers of squamous cell carcinogenesis.
Braut T; Krstulja M; Marijić B; Maržić D; Kujundžić M; Brumini G; Vučinić D; Oštarijaš E
Pathol Res Pract; 2019 Jan; 215(1):144-150. PubMed ID: 30455127
[TBL] [Abstract][Full Text] [Related]
29. Clinical and histopathological correlates of the proliferative activity in squamous cell laryngeal carcinoma.
Bayazit Y; Bakir K; Ucak R; Mumbuc S; Ozer E; Kanlikama M
Rev Laryngol Otol Rhinol (Bord); 2002; 123(1):43-6. PubMed ID: 12201000
[TBL] [Abstract][Full Text] [Related]
30. Telomerase catalytic subunit in laryngeal carcinogenesis--an immunohistochemical study.
Luzar B; Poljak M; Gale N
Mod Pathol; 2005 Mar; 18(3):406-11. PubMed ID: 15375434
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions.
Chatrath P; Scott IS; Morris LS; Davies RJ; Rushbrook SM; Bird K; Vowler SL; Grant JW; Saeed IT; Howard D; Laskey RA; Coleman N
Br J Cancer; 2003 Sep; 89(6):1048-54. PubMed ID: 12966424
[TBL] [Abstract][Full Text] [Related]
32. Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity.
Loda M; Lipman J; Cukor B; Bur M; Kwan P; DeLellis RA
Hum Pathol; 1994 Oct; 25(10):1050-6. PubMed ID: 7927309
[TBL] [Abstract][Full Text] [Related]
33. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific?
Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Alvegård T; Rydholm A
APMIS; 1995 Nov; 103(11):797-805. PubMed ID: 8546844
[TBL] [Abstract][Full Text] [Related]
34. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
Haerslev T; Jacobsen GK; Zedeler K
Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
[TBL] [Abstract][Full Text] [Related]
35. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
Cheville JC; Terrell RB; Cohen MB
Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic significance of Ki 67 and PCNA expression in laryngeal squamous cell carcinoma (morphometric evaluation of labelling index-L1].
Woźniak A; Golusiński W; Kaczmarek E; Kaczmarek J; Kaczmarek J
Otolaryngol Pol; 2002; 56(4):437-43. PubMed ID: 12378803
[TBL] [Abstract][Full Text] [Related]
37. Ki-67 immunostaining and prognosis in laryngeal cancer.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T
Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):539-42. PubMed ID: 9884809
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of proliferating cell nuclear antigen (PCNA) in the advanced cancer of larynx.
Dobroś W; Ryś J; Niezabitowski A; Olszewski E
Auris Nasus Larynx; 1998 Sep; 25(3):295-301. PubMed ID: 9799997
[TBL] [Abstract][Full Text] [Related]
39. Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies.
Yang WI; Efird JT; Quintanilla-Martinez L; Choi N; Harris NL
Hum Pathol; 1996 Jan; 27(1):70-6. PubMed ID: 8543314
[TBL] [Abstract][Full Text] [Related]
40. Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer.
Lörz M; Meyer-Breiting E; Bettinger R
Eur Arch Otorhinolaryngol; 1994; 251(2):91-4. PubMed ID: 7517683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
